T 1790/13 (Growth rates control partitioning of recombinant proteins between periplasm in E. coli and supernatant/UCB PHARMA) of 18.01.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T179013.20190118
- Date of decision
- 18 January 2019
- Case number
- T 1790/13
- Petition for review of
- -
- Application number
- 04768294.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods for producing recombinant proteins
- Applicant name
- UCB Pharma, S.A.
- Opponent name
- Lonza AG
Olswang LLP - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Claims as granted
Claims - requirements of the EPC met (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.